Increasing Employer Coverage and Maximizing Fertility Benefits

Opinion
Video

An expert shares insight into expanding employer fertility coverage to maximize benefits and access to fertility care for employees.

This is a video synopsis/summary of a Population Health Perspectives® involving Sean Tipton.In the video, Tipton states that most patients do not understand how to maximize health insurance benefits, especially for reproductive medicine, where substantial coverage gaps exist. He notes the learning curve is steeper for fertility issues compared with a broken leg. People rarely proactively ensure robust coverage for potential future fertility challenges. Tipton advisesestablishing clear, comprehensive policies. He warns there are many chances for patients to drop out of infertility treatment, which should represent thoughtful rather than frustration-driven decisions. The American Society for Reproductive Medicine (ASRM) has focused advocacy on convincing employers and payers to expand access through better coverage. Tipton reports ASRM helped fund Resolve (the National Infertility Association) to educate employees on lobbying their human resources departments for enhanced benefits. He has found fertility coverage misperceived as costlier than it really is. Simply informing companies of normative offerings and costs has increased provision.

Video synopsis is AI generated and reviewed by Managed Healthcare Executive® editorial staff.

Related Videos
Video 5 - "Obstacles in Adapting Diabetes Technology to Individual Needs" - 1 KOL is featured
Video 4 - "The Impact of Continuous Glucose Monitors & Digital Solutions on Diabetes Care"
Video 3 - "The Pivotal Role of Patient Engagement and Education in Achieving Optimal Diabetes Outcomes"
Video 2 - "Addressing Coexisting Conditions: Keys to Comprehensive Diabetes Care"
Video 1 - "The Influence of Social Determinants of Health on Diabetes Care and Outcomes"
Video 4 - "Enhancing Patient Understanding and Treatment Adherence"
Video 2 - "Overview of Treatments for Atopic Dermatitis"
© 2024 MJH Life Sciences

All rights reserved.